Unraveling the secrets of a double life: Contractile versus signaling Ca 2+ in a cardiac myocyte

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 2, 2012, Pages 317-322

  Goonasekera, Sanjeewa A ^a   Molkentin, Jeffery D ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Calcium; Contraction; Heart; Hypertrophy; Signaling

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL L TYPE; CALCIUM ION; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; RYANODINE RECEPTOR 2; SODIUM PROTON EXCHANGE PROTEIN 1; TRANSCRIPTION FACTOR NFAT; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

APOPTOSIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL MEMBRANE DEPOLARIZATION; CELL ORGANELLE; CYTOSOL; GENETIC TRANSCRIPTION; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; REVIEW; SARCOLEMMA; SIGNAL TRANSDUCTION; STIMULUS RESPONSE;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CARDIOMEGALY; HUMANS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC;

EID: 84856009646     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.05.001     Document Type: Review

References (79)

1. Bers D.M. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 2008, 70:23-49.
2. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell Apr 17 1998, 93(2):215-228.
3. van Oort R.J., Respress J.L., Li N., Reynolds C., De Almeida A.C., Skapura D.G., et al. Accelerated development of pressure overload-induced cardiac hypertrophy and dysfunction in an RyR2-R176Q knockin mouse model. Hypertension Apr 2010, 55(4):932-938.
4. 2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest Mar 2006, 116(3):675-682.
5. Muth J.N., Bodi I., Lewis W., Varadi G., Schwartz A. A Ca(2+)-dependent transgenic model of cardiac hypertrophy: a role for protein kinase Calpha. Circulation Jan 2 2001, 103(1):140-147.
6. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol Aug 2006, 7(8):589-600.
7. Kehat I, Molkentin JD. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation Dec 21 2010;122(25):2727-35.
8. Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T.B., Flegal K., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation Jan 27 2009, 119(3):480-486.
9. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol Jul 2003, 4(7):517-529.
10. Bers D.M., Guo T. Calcium signaling in cardiac ventricular myocytes. Ann NY Acad Sci Jun 2005, 1047:86-98.
11. Sampson K.J., Kass R.S. Molecular mechanisms of adrenergic stimulation in the heart. Heart Rhythm Aug 2010, 7(8):1151-1153.
12. 2+ signal integrators. Proc Natl Acad Sci USA Feb 26 2008, 105(8):2859-2864.
13. Luo W., Grupp I.L., Harrer J., Ponniah S., Grupp G., Duffy J.J., et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res Sep 1994, 75(3):401-409.
14. 2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest Jul 15 1997, 100(2):380-389.
15. 2+-channels: implications for fibrosis and heart rate in mice. Cardiovas Res Dec 1 2009, 84(3):396-406.
16. 2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest Sep 2007, 117(9):2431-2444.
17. 2+ loading preceded by a hypercontractile state and diastolic failure in the alpha(1C)TG mouse. PLoS One 2009, 4(1):e4133.
18. 2+ signal integrators. Ann NY Acad Sci Mar 2008, 1123:64-68.
19. Chen X., Nakayama H., Zhang X., Ai X., Harris D.M., Tang M., et al. Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy. J Mol Cell Cardiol Mar 2011, 50(3):460-470.
20. Xia Y., McMillin J.B., Lewis A., Moore M., Zhu W.G., Williams R.S., et al. Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene. J Biol Chem Jan 21 2000, 275(3):1855-1863.
21. Shen T., Liu Y., Cseresnyes Z., Hawkins A., Randall W.R., Schneider M.F. Activity- and calcineurin-independent nuclear shuttling of NFATc1, but not NFATc3, in adult skeletal muscle fibers. Mol Biol Cell Apr 2006, 17(4):1570-1582.
22. Valdes J.A., Gaggero E., Hidalgo J., Leal N., Jaimovich E., Carrasco M.A. NFAT activation by membrane potential follows a calcium pathway distinct from other activity-related transcription factors in skeletal muscle cells. Am J Physiol Cell Physiol Mar 2008, 294(3):C715-C725.
23. 2+ signalling and gene expression. J Physiol Jan 15 2004, 554(Pt 2):309-320.
24. 2+ response amplitude and duration. Nature Apr 24 1997, 386(6627):855-858.
25. + currents after myocardial infarction. Circ Res May 28 2004, 94(10):1340-1350.
26. Kassiri Z., Zobel C., Nguyen T.T., Molkentin J.D., Backx P.H. Reduction of I(to) causes hypertrophy in neonatal rat ventricular myocytes. Circ Res Mar 22 2002, 90(5):578-585.
27. Zobel C., Kassiri Z., Nguyen T.T., Meng Y., Backx P.H. Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes. Circulation Oct 29 2002, 106(18):2385-2391.
28. Dolmetsch R.E., Xu K., Lewis R.S. Calcium oscillations increase the efficiency and specificity of gene expression. Nature Apr 30 1998, 392(6679):933-936.
29. Cerrone M., Colombi B., Santoro M., di Barletta M.R., Scelsi M., Villani L., et al. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. Circ Res May 27 2005, 96(10):e77-e82.
30. 2+ handling and causes complex ventricular arrhythmias in mice. Cardiovasc Res Jul 1 2007, 75(1):69-78.
31. Kannankeril P.J., Mitchell B.M., Goonasekera S.A., Chelu M.G., Zhang W., Sood S., et al. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy. Proc Natl Acad Sci USA Aug 8 2006, 103(32):12179-12184.
32. Wehrens X.H., Lehnart S.E., Huang F., Vest J.A., Reiken S.R., Mohler P.J., et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell Jun 27 2003, 113(7):829-840.
33. Wehrens X.H., Marks A.R. Molecular determinants of altered contractility in heart failure. Ann Med 2004, 36(Suppl 1):70-80.
34. Shan J., Betzenhauser M.J., Kushnir A., Reiken S., Meli A.C., Wronska A., et al. Role of chronic ryanodine receptor phosphorylation in heart failure and beta-adrenergic receptor blockade in mice. J Clin Invest Dec 1 2010, 120(12):4375-4387.
35. Shan J., Kushnir A., Betzenhauser M.J., Reiken S., Li J., Lehnart S.E., et al. Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. J Clin Invest Dec 1 2010, 120(12):4388-4398.
36. 2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes?. Sci Signal 2008, 1(25):pe31.
37. 2+-ATPase superinhibition and cardiac remodeling. Circulation Feb 21 2006, 113(7):995-1004.
38. Pogwizd S.M., Schlotthauer K., Li L., Yuan W., Bers D.M. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res Jun 8 2001, 88(11):1159-1167.
39. Gaughan J.P., Furukawa S., Jeevanandam V., Hefner C.A., Kubo H., Margulies K.B., et al. Sodium/calcium exchange contributes to contraction and relaxation in failed human ventricular myocytes. Am J Physiol Aug 1999, 277(2 Pt 2):H714-H724.
40. Hobai I.A., O'Rourke B. Enhanced Ca(2+)-activated Na(+)-Ca(2+) exchange activity in canine pacing-induced heart failure. Circ Res Oct 13 2000, 87(8):690-698.
41. Jordan M.C., Henderson S.A., Han T., Fishbein M.C., Philipson K.D., Roos K.P. Myocardial function with reduced expression of the sodium-calcium exchanger. J Card Fail Sep 2010, 16(9):786-796.
42. Nakayama H., Bodi I., Maillet M., DeSantiago J., Domeier T.L., Mikoshiba K., et al. The IP3 receptor regulates cardiac hypertrophy in response to select stimuli. Circ Res Sept 3 2010, 107(5):659-666.
43. 2+ transients and arrhythmias associated with cardiac hypertrophy. Proc Natl Acad Sci USA Jul 7 2009, 106(27):11406-11411.
44. 2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice. Circ Res Jun 24 2005, 96(12):1274-1281.
45. 2+ signals that induce cardiac hypertrophy and heart failure. Circ Res Oct 10 2008, 103(8):891-899.
46. Frey N., Richardson J.A., Olson E.N. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc Natl AcadSci USA Dec 19 2000, 97(26):14632-14637.
47. 2+ channels. J Biol Chem Jan 28 2011, 286(4):2433-2444.
48. Watanabe H., Murakami M., Ohba T., Ono K., Ito H. The pathological role of transient receptor potential channels in heart disease. Circ J Mar 2009, 73(3):419-427.
49. Wu X., Eder P., Chang B., Molkentin J.D. TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proc Natl Acad Sci USA Apr 13 2010, 107(15):7000-7005.
50. Escobar M., Cardenas C., Colavita K., Petrenko N.B., Franzini-Armstrong C. Structural evidence for perinuclear calcium microdomains in cardiac myocytes. J Mol Cell Cardiol Mar 2011, 50(3):451-459.
51. 2+ delivery system in muscle cells. Appl Physiol Nutr Metab Jun 2009, 34(3):323-327.
52. Balijepalli R.C., Foell J.D., Hall D.D., Hell J.W., Kamp T.J. Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation. Proc Natl Acad Sci USA May 9 2006, 103(19):7500-7505.
53. Balijepalli R.C., Kamp T.J. Caveolae, ion channels and cardiac arrhythmias. Prog Biophys Mol Biol Oct-Nov 2008, 98(2-3):149-160.
54. Galbiati F., Engelman J.A., Volonte D., Zhang X.L., Minetti C., Li M., et al. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J Biol Chem Jun 15 2001, 276(24):21425-21433.
55. 2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice. J Clin Invest Dec 2009, 119(12):3787-3796.
56. 2+ channel. Circ Res Jul 2 2009, 105(1):51-60.
57. Coghlan V.M., Perrino B.A., Howard M., Langeberg L.K., Hicks J.B., Gallatin W.M., et al. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science Jan 6 1995, 267(5194):108-111.
58. Hall D.D., Davare M.A., Shi M., Allen M.L., Weisenhaus M., McKnight G.S., et al. Critical role of cAMP-dependent protein kinase anchoring to the L-type calcium channel Cav1.2 via A-kinase anchor protein 150 in neurons. Biochemistry Feb 13 2007, 46(6):1635-1646.
59. 2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents. J Clin Invest Apr 2009, 119(4):976-985.
60. Frey N., McKinsey T.A., Olson E.N. Decoding calcium signals involved in cardiac growth and function. Nat Med Nov 2000, 6(11):1221-1227.
61. 2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy. J Biol Chem May 19 2000, 275(20):15239-15245.
62. Colomer J.M., Means A.R. Chronic elevation of calmodulin in the ventricles of transgenic mice increases the autonomous activity of calmodulin-dependent protein kinase II, which regulates atrial natriuretic factor gene expression. Mol Endocrinol Aug 2000, 14(8):1125-1136.
63. Backs J., Backs T., Neef S., Kreusser M.M., Lehmann L.H., Patrick D.M., et al. The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci USA Feb 17 2009, 106(7):2342-2347.
64. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., Olson E.N. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell Aug 23 2002, 110(4):479-488.
65. Backs J., Song K., Bezprozvannaya S., Chang S., Olson E.N. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest Jul 2006, 116(7):1853-1864.
66. 2+ in cardiac myocytes. Biophys J Nov 15 2008, 95(10):4597-4612.
67. 2+ release is a nexus for hypertrophic signaling in cardiac myocytes. Mol Cell Feb 27 2009, 33(4):472-482.
68. Eder P., Molkentin J.D. TRPC channels as effectors of cardiac hypertrophy. Circ Res Jan 21 2011, 108(2):265-272.
69. Voelkers M., Salz M., Herzog N., Frank D., Dolatabadi N., Frey N., et al. Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes. J Mol Cell Cardiol Jun 2010, 48(6):1329-1334.
70. Philipp S., Hambrecht J., Braslavski L., Schroth G., Freichel M., Murakami M., et al. A novel capacitative calcium entry channel expressed in excitable cells. EMBO J Aug 3 1998, 17(15):4274-4282.
71. Smyth J.T., Hwang S.Y., Tomita T., DeHaven W.I., Mercer J.C., Putney J.W. Activation and regulation of store-operated calcium entry. J Cell Mol Med Oct 2010, 14(10):2337-2349.
72. Cheng K.T., Ong H.L., Liu X., Ambudkar I.S. Contribution of TRPC1 and Orai1 to Ca(2+) entry activated by store depletion. Adv Exp Med Biol 2011, 704:435-449.
73. Kinoshita H., Kuwahara K., Nishida M., Jian Z., Rong X., Kiyonaka S., et al. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart. Circ Res Jun 25 2010, 106(12):1849-1860.
74. Seth M., Zhang Z.S., Mao L., Graham V., Burch J., Stiber J., et al. TRPC1 channels are critical for hypertrophic signaling in the heart. Circ Res Nov 6 2009, 105(10):1023-1030.
75. Bush E.W., Hood D.B., Papst P.J., Chapo J.A., Minobe W., Bristow M.R., et al. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J Biol Chem Nov 3 2006, 281(44):33487-33496.
76. Kuwahara K., Wang Y., McAnally J., Richardson J.A., Bassel-Duby R., Hill J.A., et al. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest Dec 2006, 116(12):3114-3126.
77. Ohba T., Watanabe H., Murakami M., Takahashi Y., Iino K., Kuromitsu S., et al. Upregulation of TRPC1 in the development of cardiac hypertrophy. J Mol Cell Cardiol Mar 2007, 42(3):498-507.
78. Kiyonaka S., Kato K., Nishida M., Mio K., Numaga T., Sawaguchi Y., et al. Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound. Proc Natl Acad Sci USA Mar 31 2009, 106(13):5400-5405.
79. Nakayama H., Wilkin B.J., Bodi I., Molkentin J.D. Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J Aug 2006, 20(10):1660-1670.